Patents Assigned to Phanes Therapeutics, Inc.
  • Anti-DLL3 antibodies and uses thereof
    Patent number: 12037391
    Abstract: Anti-DLL3 antibodies and antigen-binding fragments thereof, anti-CD47 antibodies and antigen-binding fragments thereof, and anti-CD47/DLL3 bispecific antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases, such as cancer and/or associated complications.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: July 16, 2024
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Haiqun Jia
  • Anti-folate receptor 1 antibodies and uses thereof
    Patent number: 11873335
    Abstract: Anti-FOLR1 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: January 16, 2024
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Haiqun Jia
  • Anti-claudin 18.2 antibodies and uses thereof
    Patent number: 11555070
    Abstract: Anti-CLDN18.2 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer and/or an inflammatory disease.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: January 17, 2023
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Haiqun Jia
  • Anti-CD47 antibodies and uses thereof
    Patent number: 11401329
    Abstract: Anti-CD47 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, inflammatory disease, infectious disease, atherosclerosis, cardiovascular disease, metabolic disease, radiation-induced injury, and/or autoimmune disease.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: August 2, 2022
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Joshua Oaks, Haiqun Jia
  • Anti-LAG-3 antibodies and uses thereof
    Patent number: 11390679
    Abstract: Anti-LAG-3 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, an inflammatory disease, an autoimmune disease, type 1 diabetes, and/or infectious diseases.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: July 19, 2022
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Haiqun Jia
  • Anti-apelin antibodies and uses thereof
    Patent number: 11365242
    Abstract: Anti-apelin antibodies and antigen-binding fragments thereof are described.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: June 21, 2022
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Arvin Tam
  • Anti-TIP-1 antibodies and uses thereof
    Patent number: 11306151
    Abstract: Anti-TIP-1 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: April 19, 2022
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Joshua Oaks
  • Anti-CD73 antibodies and uses thereof
    Patent number: 11299550
    Abstract: Anti-CD73 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: April 12, 2022
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou, Fen Pei
  • Anti-TIM-3 antibodies and uses thereof
    Patent number: 11214615
    Abstract: Anti-TIM-3 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer, an inflammatory disease, an autoimmune disease, a metabolic disease, and/or infectious diseases.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: January 4, 2022
    Assignee: Phanes Therapeutics, Inc.
    Inventors: Minghan Wang, Hui Zou